---
title: "Analysts Have Conflicting Sentiments on These Healthcare Companies: Inmune Bio (INMB) and Joint (JYNT)"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/285829082.md"
description: "Analysts Have Conflicting Sentiments on These Healthcare Companies: Inmune Bio (INMB) and Joint (JYNT)"
datetime: "2026-05-10T04:47:21.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/285829082.md)
  - [en](https://longbridge.com/en/news/285829082.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/285829082.md)
---

# Analysts Have Conflicting Sentiments on These Healthcare Companies: Inmune Bio (INMB) and Joint (JYNT)


### Related Stocks

- [JYNT.US](https://longbridge.com/en/quote/JYNT.US.md)
- [INMB.US](https://longbridge.com/en/quote/INMB.US.md)
- [IHF.US](https://longbridge.com/en/quote/IHF.US.md)
- [XBI.US](https://longbridge.com/en/quote/XBI.US.md)
- [IBBQ.US](https://longbridge.com/en/quote/IBBQ.US.md)
- [IBB.US](https://longbridge.com/en/quote/IBB.US.md)
- [XHS.US](https://longbridge.com/en/quote/XHS.US.md)
- [BBH.US](https://longbridge.com/en/quote/BBH.US.md)
- [PBE.US](https://longbridge.com/en/quote/PBE.US.md)
- [LABU.US](https://longbridge.com/en/quote/LABU.US.md)
- [VHT.US](https://longbridge.com/en/quote/VHT.US.md)
- [BIB.US](https://longbridge.com/en/quote/BIB.US.md)
- [XLV.US](https://longbridge.com/en/quote/XLV.US.md)
- [IXJ.US](https://longbridge.com/en/quote/IXJ.US.md)
- [FBT.US](https://longbridge.com/en/quote/FBT.US.md)
- [SBIO.US](https://longbridge.com/en/quote/SBIO.US.md)

## Related News & Research

- [UnitedHealth Group Incorporated $UNH Holdings Boosted by GSA Capital Partners LLP](https://longbridge.com/en/news/286878927.md)
- [LifeSci Capital Sticks to Their Buy Rating for Tenax Therapeutics (TENX)](https://longbridge.com/en/news/286648286.md)
- [Phoenix Financial Ltd. Grows Position in UnitedHealth Group Incorporated $UNH](https://longbridge.com/en/news/286549656.md)
- [Zacks Research Issues Optimistic Estimate for UNH Earnings](https://longbridge.com/en/news/286908689.md)
- [Roth MKM Sticks to Their Buy Rating for Capricor Therapeutics (CAPR)](https://longbridge.com/en/news/286497683.md)